Cost of new breast cancer drug could break the bank - kotanow.com- Scottsbluff Area News, Sports, and Weather

Cost of new breast cancer drug could break the bank

Posted: Updated:

A newly approved drug for late-stage metastatic breast cancer should be readily available soon.  But one KOTA Territory doctor fears the cost will break the bank for patients. 

A new antibody drug called Kadcyla is being called a 'break through drug' for it's ability to prolong the survival rate in women who have failed other breast cancer treatments.

Kadcyla allows for a directed killing against cancer cells, and not against normal cells.

The drug causes fewer side-effects than other alternatives because the chemo therapy drug isn't released into the bloodstream.

Regional West Oncologist and Hematologist, Clint Merrill, M.D., says that by nature, new drugs are always very expensive and Kadcyla is no exception.

"The problem is going to be... What are the out of pocket costs going to be for people with insurance and how good are the patient assistance programs going to be for obtaining to drug in people without insurance," says Dr. Merrill.

The drug's wholesale price is just under $10,000 per month and will be considerably more expensive in private clinics and hospitals.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KDUH. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.